GTSE1 is possibly involved in the DNA damage repair and cisplatin resistance in osteosarcoma

被引:0
作者
Chaofan Xie
Wei Xiang
Huiyong Shen
Jingnan Shen
机构
[1] The First Affiliated Hospital of Sun Yat-Sen University,Department of Orthopaedic
[2] The Eighth Affiliated Hospital of Sun Yat-Sen University,Department of Orthopaedic
[3] The First Affiliated Hospital of Sun Yat-Sen University,Department of Muscularskeletal Oncology
来源
Journal of Orthopaedic Surgery and Research | / 16卷
关键词
Osteosarcoma; GTSE1; DNA repair; Cisplatin; Drug resistance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 240 条
[1]  
Brown HK(2017)Cancer stem cells in osteosarcoma Cancer Lett 386 189-195
[2]  
Tellez-Gabriel M(2002)Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols J Clin Oncol 20 776-790
[3]  
Heymann D(2017)Mesenchymal stroma: role in osteosarcoma progression Cancer Lett 405 90-99
[4]  
Bielack SS(2015)Bone microenvironment signals in osteosarcoma development Cell Mol Life Sci 72 3097-3113
[5]  
Kempf-Bielack B(2015)Osteosarcoma: current treatment and a collaborative pathway to success J Clin Oncol 33 3029-3035
[6]  
Delling G(2016)Osteosarcoma: cells-of-origin, cancer stem cells, and targeted therapies Stem Cells Int 2016 3631764-8852
[7]  
Exner GU(2020)Bone microenvironment and osteosarcoma metastasis Int J Mol Sci 2012 8845-62
[8]  
Flege S(2012)A meta-analysis of osteosarcoma outcomes in the modern medical era Sarcoma 23 331-236
[9]  
Helmke K(2005)Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups J Clin Oncol 10 57-647
[10]  
Kotz R(2020)Targeting molecular mechanisms underlying treatment efficacy and resistance in osteosarcoma: a review of current and future strategies Int J Mol Sci 481 229-11752